share_log

Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $216

Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $216

Keybanc維持對重症監護病房醫療的增持,將目標股價上調至216美元
Benzinga ·  2023/05/09 05:27

Keybanc analyst Matthew Mishan maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $200 to $216.

Keybanc分析師馬修·米山維持ICU Medical(納斯達克股票代碼:ICUI)的增持,並將目標股價從200美元上調至216美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論